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The establishment of donor-specific transplantation tolerance universally ob-
served in stable bone marrow (BM)' chimeras has stimulated several studies on
the tolerogenic role of donor-type cells in the induction and maintenance of an
alloantigen-specific unresponsive state . Infusion of allogeneic lymphohemato-
poietic cells into immunologically immature or immunosuppressed recipients
may under certain circumstances lead to the induction ofpermanent tolerance
to allografts, as opposed to the mere prolongation of allograft survival obtained
in unreconstituted hosts (1-4) . We have studied the mechanism underlying
transplantation tolerance induced by total lymphoid irradiation (TLI). In rodents
(mice and rats) treated by TLI, tolerance to allogeneic skin grafts can be induced
only if donor-type BM cells are also infused (5, 6) . Tolerance to perfused organ
allografts can be induced in rats (6) and baboons (7) withoutconcomitant infusion
of marrow cells, suggesting that the organ itself may provide sufficient tolero-
genic signals .
Bone marrow transplantation (BMT) of semiallogeneic combinations in which
parental BM cells were infused into TLI-conditioned F, hybrids was shown to
result in chimeric mice without clinical signs of graft vs . host disease (GVHD)
(8). We could not find evidence of donor- or host-type cellular suppression to
explain the specific unresponsiveness of the graft against the foreign parental
antigens of the Ft hosts (9) .
Splenocytes derived from chimeric mice could transfer tolerance to skin
allograft upon injection into irradiated adoptive recipients syngeneic to the
original hosts, but could not convey skin tolerance in donor-type adoptive
recipients lacking the histocompatibility antigens of the tolerizing hosts (10) .
These results indicated the possible significance of persistent alloantigen-pre-
senting cells in tolerance .
Intrigued by the possible role of tolerogenic alloantigens in induction and
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maintenance of transplantation tolerance, we designed an experimental model
to help clarify this issue . Our data, presented here, indicate that presentation of
tolerogen is not sufficient for tolerance induction . However, once induced, the
maintenance of unresponsive state definitely depends on the persistent presence
of the tolerogen ; alloantigen-specific unresponsiveness identified by limiting-
dilution analysis (LDA) could be abrogated simply by transferring the tolerant
cells into a tolerogen-free environment .
Materials and Methods
Animals .
￿
Inbred BALB/c (H-2d ) (BALB), C57BL/6 (H-2 b) (C57), (BALB/c X
C57BL/6)F, (H-2d/b) (F,), and C3H/He (H-2 k ) (C3H) were purchased from the Hebrew
University Animal Farm in Jerusalem, Israel . Recipient mice aged 3-5 mo were subjected
to TLI treatment or to whole-body irradiation (WBI), while 6-8-wk-old mice were used
as bone marrow donors. All animals were kept in standard, nonprotected animal facilities .
Total Lymphoid Irradiation.
￿
Mice were anesthetized with pentrane and a mixture of
halotane, N20, and 02 for proper positioning in an apparatus designed to expose the
major lymph nodes, thymus, and spleen while shielding most of the skull, ribs, lungs, hind
legs, and tail with lead, as previously described (5) . TLI consisted of eight exposures of
200 rad/d, six times per week, to a total dose of 1,600 rad delivered from a Phillips x-ray
unit (250 kV, 20 mA) at a rate of 50-70 rad/min . The source-to-skin distance was 40 cm,
and a 0.2-mm Cu filter was used .
Whole Body Irradiation.
￿
WBI was delivered from the same x-ray source as TLI, using
different doses, as specified in each experiment .
Cell Irradiation .
￿
Single-cell suspensions were irradiated in vitro using a radioactive
cobalt source (Gamma Cell 220 ; Atomic Energy of Canada, Ltd ., Toronto, Canada) .
Induction of Chimeras .
￿
Recipient F, mice received TLI (1,600 rad) followed by 200
rad WBI 24 h after the last fraction of TLI . Donor BM cells were isolated by flushing
RPMI-1640 (Biological Industries, Kibbutz Beit Haemek, Israel) through the shafts of the
femura and tibiae of donor mice . BM cells were washed once, and aliquots of 0.25 ml
medium containing 3 .0 X 10' live nucleated cells were injected into the lateral tail vein
of recipient mice 24 h after WBI .
Assayfor Chimerism .
￿
The percentage of donor-type cells in treated F, recipients was
assayed using BALB anti-C57 and C57 anti-BALB antisera in a complement-dependent
microcytotoxicity test as previously described (9) . All chimeras used in this study displayed
>85% donor-type cells in their peripheral blood .
Adoptive Transfer Experiments .
￿
Supralethal WBI of 1,800 rad was given to BALB or
C57 mice to inactivate all alloreactive cells and their precursors . After 3 h, mice were
injected intravenously with 6.0-10.0 X 10 7 lymphohematopoietic cells derived from
mixtures ofBM, spleen, and lymph nodes of either normal mice or long-term chimeras
(,100 d after BMT) . On the fifth day after irradiation, splenocytes of the adoptively
transferred recipients were harvested and analyzed for cytotoxic T lymphocyte precursors
(pCTL) in LDA .
Multiple Exposures to Tolerogen-presenting Cells .
￿
Normal C57 or BALB splenocytes
were washed twice and irradiated (3,000 rad) before injection, either intraperitoneally or
both intraperitoneally and intravenously, as specified in each experiment.
Limiting-dilution Cultures (LDC) .
￿
Splenocytes were plated in LDC as described previ-
ously (9) . Briefly, varying numbers (usually 250-32,000) ofresponding spleen cells (either
chimeric or from normal mice) were plated in round-bottom microtiter wells (Nunc
Roskilde, Denmark) at 16-24 wells/cell dilution with a great excess (10 6 ) of irradiated
(3,000 rad) stimulating (BALB, C57 or C3H) splenocytes and T cell growth factor(TCGF ;
5 U/well) (11) in a final volume of 0.2 ml . In mixing experiments, normal and chimeric
cells were plated in a 1 :1 ratio in LDC . After incubation for 8-9 d, the contents of each
well were mixed and 100-jul aliquots from individual wells were transferred to conical-
bottom microtiter wells (Nunc) for testing in a 4-h "Cr-release assay (9), using the1470
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appropriate "Cr-labeled target cell bearing the H-2 antigens to which the cells were
sensitized in LDC .
Cytotoxically negative wells were defined as those in which "Cr release counts did not
exceed three standard deviations of the mean ofthe "Cr released in wells originally plated
with stimulating cells only (spontaneous release) . pCTL frequencies (f) and correlation
coefficients (r2) of regression analysis for Poisson distributions were calculated from
plotting the percentage of noncytolytic cultures in each group of wells against the number
of cells originally plated in the wells, as described elsewhere (12). In all experiments, r2
values of all curves were >0 .9 .
Depletion ofT Lymphocytes.
￿
10 7 cells/ml BM cells were incubated with monoclonal anti-
Thy-1 .2 antibody (CL8600-A ; Cedarlane Laboratories, Ontario, Canada ; final dilution
1 :500) . The mixture was incubated for 1 h at 4°C with occasional shaking, after which
the cells were pelleted, resuspended in fresh rabbit serum diluted 1 :5 (complement), and
incubated for 30 min at 37°C in a 5% C0 2 in air incubator . The proportion of T
lymphocytes, determined by trypan blue exclusion, indicated 12% dead cells in BM
treated by anti-Thy-1 .2 antibody, as compared with 4% dead cells in a similar preparation
treated with complement alone .
Results
pCTL Frequencies Directed Against Host and Third-party Alloantigens ofNormal
and Chimeric Splenocytes . BALB ---+ F, chimeras containing 90-95% donor-type
(BALB) cells in peripheral blood were sacrificed on days 42 and 395 after
transplantation . Splenocytes harvested from these chimeras and splenocytes
derived from normal BALB mice were plated in LDC, and frequencies ofpCTL
directed against host-type alloantigens (H-2b) as well as against unrelated target
cells (H-2k) were estimated .
Table I shows that, at 42 d after transplant, the frequency of anti-H-2bpCTL
in BALB ---> F, chimeric splenocytes is at least 14-fold lower than that observed
in normal BALB spleen cells (<1 :300,000 and 1 :21,000, respectively) . The low
frequency of anti-H-2bpCTL was maintained in chimeric splenocytes harvested
on day 395 after transplantation (1 :81,500 vs . 1 :5820 in normal splenocytes) .
The frequency of pCTL directed against unrelated H-2k alloantigens among
chimeric splenocytes was eightfold lower on day 42 after transplantation
(1 :59,000 vs . 1 :6800 in normal splenocytes), but was restored to a normal level
on day 395 after transplantation (1 :11,900 vs. 1 :9,770 in normal splenocytes)
(Table I) .
To ascertain whether suppressor cells in the chimeric cell population are
TABLE I
pCTL Frequencies Directed against Host (H-2") and Third-party (H-2k)
Alloantigens ofNormal and BALB --), F, Chimera Splenocytes
Anti-H-2° pCTL frequency Anti-H-2° pCTL
Responding cells in
LDC 42dafter
BMT
395 d after
BMT
frequency
42 d after
BMT
395 dafter
BMT
Normal BALB 1 :21,000 1 :5,820 1 :6,800 1 :9,770
BALB-- F, chimeras <1 :300,000 1 :81,500 1 :59,000 1 :11,900
1 :1 Mixture of normal 1 :30,000 1 :6,730 1 :4,300 1 :6,830
BALB and BALB
F, chimerasTABLE II
pCTL Frequency ofBALB Cells Tolerant to C57 Obtainedfrom
BALB
￿
F, Chimeras (H-2d -+H-2d1°) afterParkingin
Supralethally Irradiated (1,800 rad) Syngeneic (H-2 d) or
Tolerogenic (H-2°) Recipients
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capable of blocking the cytotoxic response of normal cells, mixtures of normal
BALB splenocytes and chimeric cells were plated in LDC . At 42 d after trans-
plantation, the anti-H-2b pCTL frequency in such mixtures was found to be
1 :30,000, similar to that found among normal BALB cells alone (1 :21,000) .
Chimeric cells harvested on day 395 after transplantation also did not suppress
the anti-H-2' responses ofnormal BALB splenocytes (pCTL frequency of 1 :6,730
in the mixed culture as compared with 1 :5,820 in normal cells alone) . In these
mixing experiments, the frequency is stated in terms ofnormal BALB cells only;
as if plated alone . Responses of normal BALB splenocytes against H-2k alloanti-
gens were equally unaffected by adding chimeric splenocytes harvested at 42 or
395 d after transplantation (Table I) . The results strongly suggest that the lower
frequency of anti-H-2b pCTL is probably not mediated by active cell-mediated
suppression, and thus supports the concept of functional clonal inactivation .
Adoptive Transfer of Chimeric Cells into Donor- or Recipient-type Secondary Hosts.
Anti-host tolerant cells derived from pooled lymphohematopoietic compartments
of stable chimeras were "parked" in supralethally irradiated secondary recipient
mice (1,800 rad) that were either syngeneic to donor-type or the other parental
haplotype of recipient-type cells of the chimera . The total number of cells in the
transferred inoculum ranged from 6 .0 x 107 to 10.0 x 107 cells/mouse . After 4
d, splenocytes of the secondary recipients were harvested and plated in LDC for
the estimation of pCTL frequency . In parallel experiments, lymphohemato-
poietic cell mixtures obtained from normal mice were transferred into suprale-
thally irradiated allogeneic and syngeneic mice, and after 4 d the splenocytes
were analyzed for pCTL frequencies . Results of representative experiments are
displayed in Tables II and 111 . Table II shows that when BALB cells tolerant to
C57 (obtained from BALB -- .* F, chimeras) were parked in supralethally irradi-
ated C57 recipients, pCTL frequency directed against the tolerated antigen
(C57) was clearly low (1 :245,000), i.e ., the same low level that was observed in
the original chimeras (Table 1) . On the other hand, when the same cells (derived
from the same pool of chimeras) were transferred into donor-type mice (BALB),
the anti-C57 pCTL frequency increased to 1 :11,500, a level comparable to that
Exp. Adoptively
transferred cells
Adoptive
recipients
pCTL
Anti-H-26
frequency
Anti-H-2 '`
1 BALB C57 1 :150 1:290
BALB BALB 1 :7,900 1 :3,440
2 BALB tolerant to C57 C57 1 :245,000 ND
BALB tolerant to C57 BALB 1 :11,500 ND
Normal fresh BALB - 1 :5,900 ND
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TABLE III
pCTL Frequency of C57 Cells Tolerant to BALB Obtainedfrom
C57 --> F, Chimeras (H-2b ->H-2d 1°) after Parking in
Supralethally Irradiated (1,800 rad) Syngeneic(H-2°) or
Tolerogenic (H-2d ) Recipients
observed in normal controls . In this experiment, normal BALB splenocytes
responding in LDC displayed an anti-C57 pCTL frequency of 1:5,900 (Table
1I) .
Similar results were obtained by parking C57 --> F, chimeric cells in suprale-
thally irradiated BALB and C57 mice (Table III) . A low frequency of pCTL
(1 :117,600) directed against the tolerogen (BALB) was observed in the BALB
adoptive recipients, which were syngeneic to the tolerated antigen. On the other
hand, a marked increase ofanti-BALBpCTL frequency was documented in the
C57 adoptive recipients that were syngeneic to donor-type cells of the chimeric
mice (pCTL frequency of 1:24,800 as compared with 1 :4,900 in normal C57
cells responding against BALB target cells) .
Adoptive transfer experiments performed with pooled lymphohematopoietic
cells obtained from normal mice were carried out to exclude "trapping" of
alloreactive cells in heavily irradiated allogeneic recipients . After parking in the
allogeneic host (C57) for 4 d, the adoptively transferred normal BALB cells
became sensitized against H-2b alloantigen, as documented by the high frequency
of pCTL directed against both host-type (H-2b) (1 :150) and unrelated (H-2k)
target cells (1 :290) (Table I1) . The high frequency of the anti-H-2 k pCTL can
most likely be ascribed to crossreactivity between C57 and C3H mouse strains .
After transfer into syngeneic hosts, the same inoculum of BALB cells displayed
anti-H-2 b and anti-H-2' pCTL frequencies (1 :7,900 and 1:3,440, respectively),
which are comparable to those found among normal BALB splenocytes (Table
I1) . Similar results were obtained when normal C57 cells were adoptively trans-
ferred into supraiethally irradiated syngeneic or allogeneic hosts (Table III) .
The high alloreactive pCTL frequencies observed when normal cells were
transferred into the allogeneic adoptive hosts is worth noting for its contrast
with those obtained by transfer of chimeric cells . While the allogeneic adoptive
host serves to sensitize normal cells, its effect on the genotypically identical
allogeneic chimeric cells is that of continued tolerization . The results obtained
with normal inocula may serve as indirect evidence against the possibility of in
vivo selective depletion of alloreactive clones .
Exp . Adoptively
transferred cells
Adoptive
recipients
pCTL
Anti-H-2d
frequency
Anti-H-2°
1 C57 BALB 1 :38 1:740
C57 C57 1 :520 1:700
2 C57 tolerant toBALB BALB 1 :117,600 ND
C57 tolerant to BALB C57 1 :24,800 ND
Normal fresh C57 - 1 :4,900 ND
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FIGURE 1 .
￿
LDA of C57 --r F, chimeric cells (C57 [H-2b] tolerant to BALB [H-2d1) after
`parking' for 4 d in supralethally irradiated (1,800 rad) BALB or C57 recipients. Adoptive
recipients syngeneic with chimeric donor type cells (C57) were exposed to daily injections of
irradiated (3,000 rad) BALB splenocytes . Frequencies ofpCTL directed against the tolerizing
(H-2d) and unrelated (H-2k) alloantigens were determined by LDA .
Control mice subjected to supralethal irradiation (1,800 rad) without lym-
phohematopoietic reconstitution survived for 5-6 d, and when sacrificed on the
fifth day their spleens were totally depleted of cells (<105 cells) . On the other
hand, 3-15 X 106 cells could be recovered from reconstituted recipients sacri-
ficed on the fifth day . We therefore assume that the cells harvested on the fifth
day after supralethal irradiation were derived entirely from the lymphohemato-
poietic inoculum transferred to the adoptive recipients .
Multiple Exposures of Adoptively Transferred Tolerant Cells to Tolerizing Alloan-
tigens in Adoptive Recipients. Adoptive recipients syngeneic to the chimeric
donors were exposed to multiple injections of irradiated tolerogen-bearing
splenocytes . Irradiated splenocytes were first introduced 18 h after lymphohe-
matopoietic reconstitution, and followed by daily injections of 6.0-8 .0 X 107
cells/mouse/d by both intravenous and intraperitonental routes for 3 d. Spleno-
cytes of the adoptive recipients were harvested on the fifth day and analyzed for
pCTL frequency directed against tolerogen- and unrelated-type cells .
Fig . 1 presents results obtained with C57 -> F I chimeric cells that were
adoptively transferred into supralethally irradiated C57 mice with or without
multiple injections of irradiated BALB splenocytes . Here again, when BALB-
tolerant C57 cells were transferred into heavily irradiated C57 mice, the low
frequency of pCTL directed against BALB target cells clearly increased, and an
almost normal alloreactive response was documented (1 :11,500). However, mul-
tiple exposures of supralethally irradiated secondary hosts (C57) to irradiated
tolerogen-bearing cells (BALB) resulted in a marked decrease in pCTL frequency
directed against BALB (1 :74,400), thus leading to the reestablishment of the1474 ALLOANTIGEN PERSISTENCE IN TRANSPLANTATION TOLERANCE
T-depleted
BM ofBALB
24 hI
Skin of
(BALBx C57)F,
Multiple injec-
tions of irradi-
ated F, spleno-
cytes daily : days
1-7, thrice
weekly : days 8-
21
* Median (range in parentheses) in days .
Skin of C57
Ion day 10
Multiple injections of ir-
radiated F, splenocytes
on days 2-10 after skin
grafting
Skin ofC57
Skin allograft survival*
32(22-38)
￿
21 (20-27)
￿
15(13-17)
n=9
￿
n=9
￿
n=10
FIGURE 2 .
￿
Design of experimental protocols used to investigate potential role of multiple
exposures of irradiated alloantigen-presenting cells in induction of unresponsiveness to allo-
geneic skin grafts .
tolerant state, as indicated by the low frequency of anti-BALB pCTL found in
the original chimeras .
A low frequency of anti-BALB pCTL (1 :58,400) could be maintained when
the chimeric inoculum was transferred into supralethally irradiated BALB mice .
Response to unrelated alloantigen (H-2 k) was similar in all three experimental
groups (1 :1,410, 1 :1,590, and 1:2,910, respectively ; Fig. 1) .
Presentation of Talerogen-bearing Cell in Induction of Tolerance.
￿
In previous
sections we have brought evidence to support the notion that persistence of
tolerogen-presenting cells is required for the maintenance of transplantation
tolerance . It was of interest as well to study the role of tolerogen-presenting cells
in induction of tolerance . We therefore designed the following experiments,
detailed in Fig. 2 .
Lethally irradiated BALB mice (600 rad) were reconstituted with T cell-
depleted syngeneic BM and F, skin was grafted after 24 h. Multiple injections of
irradiated F, spleen cells were given intraperitoneally every day for the first
week, followed by three injections per week over the next 2 wk . Skin rejection
by all nine mice tested was observed between days 22-38 with a median of32 d
(Fig . 2A).
A B C
BALG BALB BALB
WBI 600 rad WBI 400 rad ~WB1 400 rad
24 h
Daily intravenous injec-
tion of irradiated F, sple-
nocytes on days 1 and 2;
Intraperitoneal injection
on days 3-7 24 hMORECKI ET AL .
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Sublethally irradiated BALB mice (400 rad) were subjected to multiple injec-
tions of irradiated F, splenocytes on days 1 and 2 (intravenously) and on days 3-
7 (intraperitoneally) after WBI (Fig. 2B) . Skin of C57 mice was grafted on day
10 after WBI, followed by continued multiple daily intraperitoneal injections of
irradiated F, splenocytes on days 2-10 after skin grafting . Skin rejection by all
nine mice was observed on days 20-27, with a median of 21 d (Fig. 2B).
Sublethally irradiated (400 rad) BALB mice were transplanted with skin of
C57 mice 24 h after WBI (Fig . 2C). This group of mice served as control for
skin graft survival after sublethal irradiation . Skin rejection by all 10 mice tested
was observed on days 13-17, with a median of 15 d. The mild delay of skin
rejection observed in Fig . 2B as compared with Fig. 2C was found to be
statistically significant (p < 0.01) . It was impossible to induce permanent survival
of skin allograft by multiple injections of irradiated splenocytes bearing the same
H-2 antigens as the skin graft, although permanent tolerance to skin allografts
was observed in one experiment using nonirradiated spleen cells in similar
experimental conditions (data not shown) .
Discussion
Tolerant mice that were conditioned with TLI and transplanted with alloge-
neic BM cells display markedly low frequencies ofpCTL directed against host-
type alloantigens . The low frequency of antihost-specific cytotoxic activity dem-
onstrated on day 42 after transplant was maintained on day 395, while at the
same time normal levels of cytotoxic cells could be raised against unrelated
alloantigens, indicating the existence of specific transplantation tolerance at the
cellular level . No evidence was found for the presence of regulatory cells to
account for chimeric hyporeactivity in previous studies (9), as well as by 1 :1
mixing experiments in the present study . We have previously shown (10) that
when chimeric cells (C57 -+ BALB) were adoptively transferred to sublethally
irradiated recipients (C57) that were syngeneic to donor-type cellsof the original
chimeras, skin allografts of the host-type (BALB) of the chimera were always
rejected . On the other hand, irradiated host-type secondary recipients (BALB)
permanently accepted skin allograft derived from mice syngeneic to donor-type
cells (C57) of the original chimeras . Similar studies were carried out in lethally
irradiated adoptive recipients of C57 --+ BALB chimeric cells to minimize the
possibility of skin graft (BALB) rejection by residual host-type (C57) immuno-
competent cells. The results of these studies indicated that BALB skin allografts
were always rejected by the secondary (C57) recipients (our unpublished data) .
In other words, tolerance was broken upon transfer into a tolerogen-free envi-
ronment. These results could be interpreted in two ways . The first is that residual
alloreactive cells of the adoptive secondary recipients were radioresistant and
could thus cause rejection of allogeneic skin . This interpretation implies that
chimeric spleen cells are not capable of suppressing rejection induced by a
relatively small number of residual alloreactive cells of the recipient . The pres-
ence of radioresistant alloreactive cells is well established in both animals and
man (13, 14) . Lethally irradiated (1,200-1,440 rad) patients with malignant
hematological disorders who also receive high-dose cyclophosphamide (120
mg/kg) are still capable of rejecting BM grafts obtained from HLA-identical1476
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siblings (15) . The second possible explanation is that tolerant cells obtained from
the chimeric spleen (C57 --3- BALB) may have lost their alloantigen-specific
unresponsiveness in the new milieu of the H-2-incompatible adoptive host (C57) .
If this were the situation, it could be suggested that the new environment to
which the chimeric cells were transferred lacks an essential constituent to main-
tain tolerance . Determining the mechanism of loss of specific unresponsiveness
in allogeneic hosts might help in understanding the mechanism of tolerance
maintenance. We therefore designed an experimental system to exclude any
chance of residual reactivity of host lymphoid cells that might play a role during
skin allograft rejection .
A supralethal irradiation dose of 1,800 rad was given to adoptive hosts before
transfer of tolerant chimeric cells . Adoptive recipients were of two different
genotypes, one syngeneic to host-type cells of the original chimeras and the other
providing the chimeric cells with an environment lacking the tolerance-inducing
H-2 haplotype . In another experiment, the chimeric cells in the tolerogen-free
adoptive recipients were exposed to repeated injections of irradiated tolerogen-
presenting cells.
The results of these experiments indicated that persistence of cells bearing the
tolerogen is mandatory to maintain immunological unresponsiveness towards a
specific alloantigen . Low frequencies of pCTL directed against the tolerogenic
cells were maintained only in tolerizing-type adoptive recipients or in those
recipients that received multiple injections of tolerogen-presenting cells. When-
ever unresponsive cellswere parked in hosts lackingthe specific tolerogen, pCTL
frequencies increasedmarkedly in the adoptive recipients within 4d. Frequencies
of pCTL directed against unrelated alloantigens were close to normal regardless
of the presence of the tolerogen-type cells in the adoptive recipients .
It could be argued that the low anti-host-type pCTL frequency observed in
the adoptive transfer experiments (chimeric C57 -* F, or BALB --* F, cells
transferred to BALB or C57 recipients, respectively) could result from a selective
in vivo adsorbance of chimeric alloreactive cells directed against the adoptive
hosts (C57 anti-BALBand BALB anti-C57, respectively) . This explanation seems
unlikely, because the original chimeric cells displayed a low frequency of pCTL
against the tolerogen-type cells. Moreover, normal cells subjected to the same
experimental conditions developed a very high anti-allogeneic pCTL frequency
as a result of in vivo sensitization occurring in the adoptive hosts, rather than
allospecific immunodepletion. This is in agreement with previously published
data (16, 17) showing that hypoalloreactivity occurred during the first 24-48 h
after priming with allogeneic lymphocytes, while marked hyperresponsiveness
occurred on days 4 and 5 after priming. Because, in our experimental model,
the splenocytes were harvested on the fifth day after infusion, negative selection
caused by depletion of alloreactive clones is not a likely explanation for the
hyporeactivity observed in chimeric cells parked in H-2-incompatible milieu .
Our results clearly indicate the requirement for the persistence of tolerizing
alloantigens in maintaining already-induced tolerance . Repeated administration
of irradiated alloantigen-presenting cells into sublethally irradiated recipients
was insufficient for the induction of permanent tolerance as documented byMORECKI ET AL .
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rejection of skin allografts in sublethally and lethally irradiated recipients (Fig .
2) .
Several reports have already suggested the crucial role of donor cells in
allograft tolerance (1-4, 18, 19). Luberofand Silver (20, 21) demonstrated the
requirement for persistence ofdonor cells for maintenance ofneonatally induced
tolerance . By injecting tolerant hosts with cytotoxic antidonor isoantisera or
transfer ofantitolerogen-sensitized lymphoid cells, they could frequently abolish
tolerance . Maki et al . (22) have shown that donorTcells with suppressive activity
might also play a role in enhancement of skin allografts in mice .
In another experimental system, the importance ofdonor lymphoid cells was
affirmed in the transfer of tolerance into secondary hosts. Dorsch and Roser
(23), using neonatally induced tolerance in rats, could not transfer tolerance to
secondary hosts if the small proportion (1-2%) of donor F, cells was removed
from the transferred inoculum in a host vs . graft tolerance model . Pierce et al .
(24), using fractionated WBI (a conditioning treatment somewhat similar to TLI)
to establish allogeneic chimeras, have shown that cells responsible for tolerance
transfer were of donor origin, and that these donor-derived cells were not only
necessary but also sufficient for tolerance transfer. In those adoptive recipients,
when donor lymphoid cells were omitted from the transferred inoculum, the
skin allografts were uniformly rejected .
In what way the tolerizing cells effect tolerance maintenance is still unknown.
Tutschka et al . (25) have provided evidence that tolerogen-bearing cells are
crucial for the continuous presence of suppressor cells responsible for mainte-
nance of transplantation tolerance . In their experimental model, chimeric sple-
nocytes that were transferred to a tolerogen-free environment displayed a
marked clonal reduction of suppressor cells, while reexposure to the tolerogen-
type cells caused clonal expansion of the memory suppressor cells .
Stephenson et al . (26, 27) and Dorsch et al . (23) suggested that the tolerogen-
bearing cells may serve as a source for alloreactive stimulation of the suppressor
cells, which probably suppress via an antiidiotypic mechanism directed against a
determinant present on the antitolerogen receptor of the alloreactive cells . This
interpretation is entirely compatible with results presented by Stockinger (28)
and Heeg et al . (29), who demonstrated removal ofsuppressor cellsby adsorbance
of tolerant cells on monolayers of syngeneic blasts bearing receptors for the
given tolerogen . In these experimental systems, the tolerogen-presenting cells
may be essential in antiidiotypic interactions that could play an important role in
transplantation tolerance . By this mechanism, small numbers of suppressor cells
may be sufficient for continuous presentation of tolerogenic signals, although
suppressive effects might be undetected in standard suppression assays of limited
sensitivity .
If immune tolerance is maintained by antiidiotypic interactions, it might fit
well into the idiotypic network concept developed from Jerne's postulates to
explain the general balance between unresponsiveness and responsiveness of the
immune system (30) .
Our experiments may also suggest an alternative explanation that we favor,
that induction/maintenance of unresponsiveness occurs already at the level of
pCTLs . The rapid loss (within 4 d) of the unresponsiveness of pCTL to alloan-1478
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tigens in the absence of tolerogen, and the demonstration of its partial or
complete restoration by tolerogen-bearing cells may indicate that maintenance
of the unresponsive state may be due simply to blocking of alloantigen receptors
on pCTL by soluble determinants of MHC antigens known to be present in
serum and other body fluids . Shedding of such MHC determinants by metabol-
ically active and dividing cells may certainly be explained by persisting cells,
whereas irradiated, short-lived cells may serve as a short-term and limited source
of tolerizing MHC determinants . The absence or, rather, undetectability of
alloantigen-specific suppressor cells in parental -+ F, chimeras (9) suggests that
the state of tolerance in TLI-induced chimeras is maintained by functional,
alloantigen-dependent, clonal reduction .
In summary, we have brought evidence showing the importance of persistent
presentation of tolerizing allogeneic cells in maintenance of tolerance to alloan-
tigens at the cellular level by limiting-dilution analysis.
Further studies on the mechanism of induction and maintenance of transplan-
tation tolerance, currently underway, are essential for understanding one of
nature's most fundamental enigmas: the discrimination between self and nonself .
Clearly, better understanding of some of these fundamental mechanisms might
provide a way to induce true transplantation tolerance to allografts .
Summary
Infusion of parental bone marrow cells into F, hybrids conditioned by total
lymphoid irradiation (TLI) results in chimeras with a high percentage of donor-
type cells, and without clinical signs of graft-vs.-host reaction . In these chimeras,
a state of tolerance has been shown to be associated with paucity of cytotoxic T
lymphocyte percursors (pCTL) reactive with host-type alloantigens. To deter-
mine whether the presence of tolerizing alloantigens is essential for maintenance
of unresponsiveness, lymphohematopoietic cells obtained from such tolerant
chimeras were transferred into supralethally irradiated recipients oftwodifferent
genotypes : in one case the adoptive recipients were syngeneic with host-type
cells, and in the other they were syngeneic with donor-type cells of the original
chimeras, thus providing the chimeric cells with a tolerogen-free environment .
After "parking" for 4 d in syngeneic donor-type mice, the transferred cells
displayeda marked increase in the frequency ofpCTL directed against tolerizing
alloantigens, whereas a lowpCTL frequency directed against the same H-2 target
cells was maintained in allogeneic tolerizing-type adoptive recipients . Multiple
injections of adoptive donor-type mice with tolerizing-type cells of the original
chimera reestablished a low level of cytotoxic precursors . Cytotoxic activity
against unrelated alloantigens was independent of the presence of tolerogen-
presenting cells in the adoptively transferred mice . Our experimental model
suggests that persistence of cells bearing tolerizing alloantigens is an essential
requirement for maintenance of previously established tolerance .
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